HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanako Ushio Selected Research

pregnancy-associated glycoprotein 1

4/2024In vitro regulation of gene expression of pregnancy-associated proteins and cytokines in bovine endometrial epithelial cells and bovine trophoblastic cells by infection with Neospora caninum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nanako Ushio Research Topics

Disease

3Infections
04/2024 - 01/2021
1Neglected Diseases
12/2023
1Schistosomiasis (Bilharziasis)
12/2023
1Ascites
01/2022
1Toxoplasmosis
11/2021
1Amyloid Plaque
01/2021
1Hypertrophy
01/2021
1Leydig Cell Tumor
01/2021
1Vasculitis (Vasculitides)
01/2021
1Atherosclerosis
01/2021
1Adenocarcinoma
01/2020
1Hyperplasia
01/2020
1Cholecystitis
01/2020
1Adenoma (Adenomas)
01/2020
1Neoplasms (Cancer)
01/2020
1Metaplasia
01/2020

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2021
2Chemokine ReceptorsIBA
01/2022 - 11/2021
1ProlactinIBA
04/2024
1Interferon-gamma (Interferon, gamma)IBA
04/2024
1pregnancy-associated glycoprotein 1IBA
04/2024
1Interleukin-8 (Interleukin 8)IBA
04/2024
1CytokinesIBA
04/2024
1Praziquantel (Biltricide)FDA Link
12/2023
1Interleukin-6 (Interleukin 6)IBA
01/2022
1InterferonsIBA
01/2022
1oxidized low density lipoproteinIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1ApolipoproteinsIBA
01/2021
1LipidsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Keratin-19 (Keratin 19)IBA
01/2020
1Keratins (Keratin)IBA
01/2020
1Periodic AcidIBA
01/2020
1Alcian BlueIBA
01/2020
1MucinsIBA
01/2020

Therapy/Procedure

1Mass Drug Administration
12/2023